Abiopharma

🔍 Thompson Teresa Brigid (Director)

Company: Synergy CHC Corp. (SNYR)

Report Date: 2026-04-21

Detailed Transactions and Holdings:

• Acquired 25,824 shares of Common Stock, par value $0.00001 per share (Direct)
  Date: 2026-04-21 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,824.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The reported securities are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.00001 per share, of Synergy CHC Corp. (the "Issuer"), subject to the conditions set forth in the applicable RSU award agreement and Issuer's 2024 Equity Incentive Plan, as amended. The RSUs vested in full on the grant date.